Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Trial Shows Oral Covid-19 Vaccine Produces Antibodies

White pills

A clinical trial shows a Covid-19 vaccine taken as a tablet produces protective antibodies in nasal membranes that in some cases last for up to a year. . . . → Read More: Trial Shows Oral Covid-19 Vaccine Produces Antibodies

Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds

Stephanie Culler

A developer of therapies produced with synthetic biology for diseases linked to microbes in the gut is raising $15 million in seed financing. . . . → Read More: Synthetic Bio Microbiome Biotech Gains $15M in Seed Funds

Infographic – US Biotech Investments Stay Strong

Chart: biotech venture investments

The first half half of 2022 shows venture investments in U.S. biotechnology start-ups cooled from the blistering pace of last year, but biotech remains a robust sector. . . . → Read More: Infographic – US Biotech Investments Stay Strong

NIH Funding Engineered Phage Screening Device

National Institutes of Health is funding initial development of a microfluidic device that tests engineered viruses for their ability to kill disease-causing bacteria. . . . → Read More: NIH Funding Engineered Phage Screening Device

Precision Protein Design Start-Up Gains $40M in Early Funds

Chemical atom model

A start-up company designing and testing precise proteins within live animals to speed creation of new therapeutics is raising $40 million in its first venture round. . . . → Read More: Precision Protein Design Start-Up Gains $40M in Early Funds

Biotechs Explore Gut-Brain Axis for Mental Health

Microbiome graphic

Two biotechnology companies are advancing basic research findings connecting gut microbes with the brain to develop new therapies for neurological disorders. . . . → Read More: Biotechs Explore Gut-Brain Axis for Mental Health

Trial Begins of Precise Gene Editing for Heart Disease

Heart and major blood vessels

A clinical trial is underway evaluating a precise form of Crispr gene editing as a one-time therapy for an inherited form of heart disease. . . . → Read More: Trial Begins of Precise Gene Editing for Heart Disease

Diabetes Cell Therapy Biotech Acquired in $320M Deal

Diabetes word cloud

A developer of therapies derived from stem cells to replace malfunctioning islet cells in people with type 1 diabetes was acquired by Vertex Pharmaceuticals. . . . → Read More: Diabetes Cell Therapy Biotech Acquired in $320M Deal

AI Analytics Find New ALS Genetic Drug Targets

Artificial intelligence graphic

Researchers analyzed medical and scientific databases with algorithms to identify eight previously unreported biomarkers contributing to neurodegeneration similar to ALS. . . . → Read More: AI Analytics Find New ALS Genetic Drug Targets

Human Organoids Show Drug Activity in Lab Animals

Goldfinch on wire cage

A study shows implanted lab-grown pieces of human 3-D kidney tissue can demonstrate chemical activity of drugs in preclinical tests with lab rats. . . . → Read More: Human Organoids Show Drug Activity in Lab Animals